kaonavi
4435
Itamiarts
168A
D. Western Therapeutics Institute
4576
Wintest
6721
Migalo Holdings
5535
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 111.52%52.38B | -39.55%24.76B | -28.06%40.96B | 54.82%56.94B | -22.60%36.78B | -23.60%47.52B | 16.23%62.2B | -2.15%53.52B | 15.63%54.69B | 9.39%47.3B |
Net profit before non-cash adjustment | 203.10%43.85B | -68.70%14.47B | 21.14%46.23B | 38.86%38.16B | 1.61%27.48B | 8.82%27.04B | -19.64%24.85B | 17.75%30.93B | -11.84%26.27B | -8.41%29.79B |
Total adjustment of non-cash items | -91.02%3.29B | 491.52%36.62B | -63.51%6.19B | -20.42%16.97B | -22.99%21.32B | -3.72%27.68B | 45.53%28.75B | -33.81%19.76B | 52.49%29.85B | -6.60%19.57B |
-Depreciation and amortization | -1.27%20.12B | -5.06%20.38B | 18.26%21.47B | 4.05%18.15B | -7.30%17.45B | -11.26%18.82B | 0.51%21.21B | -2.19%21.1B | 7.29%21.57B | 13.63%20.11B |
-Reversal of impairment losses recognized in profit and loss | -86.85%2.55B | 837.17%19.39B | --2.07B | ---- | ---- | -41.75%8.61B | 7,929.89%14.78B | --184M | ---- | 15,687.50%1.26B |
-Disposal profit | -729.51%-22.46B | -394.35%-2.71B | 134.10%920M | -68.38%393M | 97.62%1.24B | 34.98%629M | -25.91%466M | 37.94%629M | --456M | ---- |
-Net exchange gains and losses | -60.52%-870M | 20.06%-542M | -52.02%-678M | ---446M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other non-cash items | 3,889.90%3.95B | 100.56%99M | -1,451.06%-17.59B | -143.13%-1.13B | 806.72%2.63B | 95.17%-372M | -256.96%-7.7B | -127.57%-2.16B | 534.87%7.82B | -155.29%-1.8B |
Changes in working capital | 119.89%5.24B | -129.80%-26.33B | -731.18%-11.46B | 115.10%1.82B | -66.76%-12.02B | -183.88%-7.21B | 203.57%8.59B | 299.37%2.83B | 31.20%-1.42B | 79.85%-2.06B |
-Change in receivables | -161.18%-1.45B | 160.52%2.38B | 20.42%-3.92B | -174.52%-4.93B | 13,685.42%6.62B | 100.83%48M | 29.11%-5.81B | -268.69%-8.2B | 369.21%4.86B | -18.17%1.04B |
-Change in inventory | 123.57%7.33B | -31.83%-31.09B | -495.27%-23.58B | 370.69%5.97B | 71.60%-2.2B | -298.15%-7.76B | -265.45%-1.95B | 138.18%1.18B | -269.60%-3.09B | 231.24%1.82B |
-Change in payables | -266.97%-1.86B | -92.62%1.11B | 6,017.48%15.05B | 101.50%246M | -1,690.50%-16.4B | -105.41%-916M | 22.66%16.93B | 296.58%13.8B | -54.38%-7.02B | 62.96%-4.55B |
-Provision for loans, leases and other losses | -4.55%1.22B | 27.37%1.28B | 87.45%1B | 1,670.59%534M | -102.40%-34M | 347.21%1.42B | 85.46%-574M | -203.24%-3.95B | 1,131.00%3.83B | -117.22%-371M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 8.08%-91M | 25.56%-99M | -4.72%-133M | 3.79%-127M | 39.73%-132M | 34.43%-219M | 26.11%-334M | 24.67%-452M | 15.97%-600M | 9.62%-714M |
Interest received (cash flow from operating activities) | -0.73%3.54B | 20.82%3.57B | 13.01%2.95B | -12.78%2.61B | 17.02%3B | 4.83%2.56B | -5.75%2.44B | 35.99%2.59B | 9.23%1.91B | 28.78%1.75B |
Tax refund paid | 32.06%-9.44B | -29.98%-13.9B | -99.57%-10.69B | 53.22%-5.36B | -10.24%-11.45B | -2.92%-10.39B | -23.15%-10.09B | 4.71%-8.2B | 44.16%-8.6B | -100.64%-15.4B |
Other operating cash inflow (outflow) | 4,563.64%1.03B | -55.10%22M | -97.56%49M | 748.10%2.01B | -74.24%237M | 273.98%920M | -84.45%246M | 691.00%1.58B | -81.40%200M | 304.14%1.08B |
Operating cash flow | 230.22%47.41B | -56.67%14.36B | -40.91%33.14B | 97.26%56.08B | -29.62%28.43B | -25.83%40.39B | 11.05%54.46B | 3.03%49.04B | 39.97%47.6B | -6.57%34.01B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -40.59%-34.1B | -3.65%-24.25B | -0.05%-23.4B | -7.33%-23.39B | -80.95%-21.79B | 0.82%-12.04B | 50.24%-12.14B | 18.43%-24.4B | -21.96%-29.91B | -3.56%-24.52B |
Net intangibles purchase and sale | 24.08%-2.32B | -241.45%-3.06B | -38.33%-895M | 51.97%-647M | -83.77%-1.35B | 38.76%-733M | 8.14%-1.2B | -49.94%-1.3B | -12.86%-869M | 15.66%-770M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --543M | ---- | ---- | ---- |
Net investment product transactions | 3,503.89%31.49B | 38.21%-925M | 3.98%-1.5B | -15.91%-1.56B | 81.79%-1.35B | -1,080.19%-7.39B | 66.36%-626M | 26.21%-1.86B | -70.98%-2.52B | 71.07%-1.48B |
Advance cash and loans provided to other parties | -8.72%-2.39B | -61.72%-2.2B | 50.40%-1.36B | 39.93%-2.74B | -117.94%-4.57B | 3.37%-2.1B | 62.68%-2.17B | -101.88%-5.81B | -184.21%-2.88B | -48.97%-1.01B |
Repayment of advance payments to other parties and cash income from loans | -54.06%679M | 866.01%1.48B | --153M | ---- | 95.75%4.47B | 11.04%2.28B | -65.29%2.06B | 161.96%5.92B | 146.30%2.26B | 159.32%918M |
Net changes in other investments | 2,000.00%1.22B | -89.68%58M | 129.53%562M | -21,244.44%-1.9B | 100.62%9M | -2.33%-1.45B | 15.14%-1.42B | -79.87%-1.67B | -1,067.71%-929M | 106.42%96M |
Investing cash flow | 81.22%-5.43B | -9.32%-28.9B | 12.58%-26.44B | -23.07%-30.24B | -14.67%-24.57B | -43.31%-21.43B | 48.66%-14.95B | 16.43%-29.12B | -30.19%-34.85B | 15.06%-26.77B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -311.11%-19B | --9B | --0 | 36.81%-2B | 77.99%-3.17B | -143.41%-14.38B | 50.20%-5.91B | -550.27%-11.86B | 79.37%-1.82B | -363.47%-8.84B |
Net common stock issuance | --0 | 33.62%-3.99B | -601,000.00%-6.01B | ---1M | ---- | -249,950.00%-5B | ---2M | ---- | -125,400.00%-3.77B | 99.94%-3M |
Increase or decrease of lease financing | -1.23%-824M | -58.67%-814M | -57.85%-513M | ---325M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash dividends paid | -14.86%-8.06B | -33.58%-7.01B | -14.33%-5.25B | -0.11%-4.59B | -15.86%-4.59B | -11.62%-3.96B | -0.03%-3.55B | -11.76%-3.55B | -7.74%-3.17B | 2.00%-2.95B |
Cash dividends for minorities | -46,650.00%-1.87B | 96.36%-4M | 26.17%-110M | -338.24%-149M | 58.54%-34M | 39.71%-82M | -312.12%-136M | 0.00%-33M | 2.94%-33M | -13.33%-34M |
Net other fund-raising expenses | -33,700.00%-336M | 0.00%1M | 100.08%1M | -143.27%-1.19B | -216.13%-490M | 92.38%-155M | -415.99%-2.03B | -83.26%-394M | -10.82%-215M | -25.97%-194M |
Financing cash flow | -966.84%-30.09B | 76.27%-2.82B | -43.88%-11.88B | 0.21%-8.26B | 64.90%-8.28B | -102.80%-23.58B | 26.58%-11.63B | -75.74%-15.83B | 25.04%-9.01B | -18.94%-12.02B |
Net cash flow | ||||||||||
Beginning cash position | -36.50%28.27B | -7.54%44.52B | 59.45%48.15B | -13.34%30.2B | -12.43%34.85B | 250.03%39.79B | 66.39%11.37B | 95.70%6.83B | -56.99%3.49B | -33.00%8.12B |
Current changes in cash | 168.54%11.9B | -235.22%-17.36B | -129.46%-5.18B | 498.14%17.58B | 4.17%-4.42B | -116.52%-4.61B | 582.31%27.89B | 9.22%4.09B | 178.28%3.74B | 8.46%-4.78B |
Effect of exchange rate changes | 59.41%1.77B | -25.64%1.11B | 366.88%1.49B | 237.93%320M | 31.36%-232M | -233.60%-338M | 256.17%253M | 59.50%-162M | -359.74%-400M | -87.41%154M |
Cash adjustments other than cash changes | 59,300.00%592M | -101.85%-1M | 3.85%54M | --52M | ---- | -99.65%1M | -53.52%284M | 61,200.00%611M | ---1M | ---- |
End cash Position | 50.45%42.53B | -36.50%28.27B | -7.54%44.52B | 59.45%48.15B | -13.34%30.2B | -12.43%34.85B | 250.03%39.79B | 66.39%11.37B | 95.70%6.83B | -56.99%3.49B |
Free cash flow | 184.90%11B | -246.39%-12.95B | -72.39%8.85B | 505.23%32.05B | -80.83%5.3B | -32.84%27.62B | 76.18%41.13B | 38.77%23.34B | 122.09%16.82B | -30.82%7.57B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |